Daniel Ahn, DO

Assistant Professor

  • 400 Citations
  • 13 h-Index
20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 19 Similar Profiles
Biliary Tract Neoplasms Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Cholangiocarcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

Watch and Wait in Rectal Cancer: Who's In and Who's Out?

Ahn, D. & Bekaii-Saab, T., Mar 1 2019, In : Journal of oncology practice. 15, 3, p. 133-134 2 p.

Research output: Contribution to journalArticle

Rectal Neoplasms
1 Citation (Scopus)

Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer

Ahn, D., Reardon, J., Ahn, C. W., Bupathi, M., Mikhail, S., Wu, C. S. Y. & Bekaii-Saab, T., Apr 15 2018, In : International Journal of Cancer. 142, 8, p. 1671-1675 5 p.

Research output: Contribution to journalArticle

gemcitabine
Biliary Tract Neoplasms
Cisplatin
Survival
Disease-Free Survival

Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer

Ramsey, M. L., Talbert, E., Ahn, D., Bekaii-Saab, T., Badi, N., Bloomston, P. M., Conwell, D. L., Cruz-Monserrate, Z., Dillhoff, M., Farren, M. R., Hinton, A., Krishna, S. G., Lesinski, G. B., Mace, T., Manilchuk, A., Noonan, A., Pawlik, T. M., Rajasekera, P. V., Schmidt, C., Guttridge, D. & 1 othersHart, P. A., Jan 1 2018, (Accepted/In press) In : Pancreatology.

Research output: Contribution to journalArticle

Cachexia
Pancreatic Neoplasms
Disease Progression
Interleukin-6
Weight Loss
Immune System
Adenocarcinoma
Neoplasms
Therapeutics
Aptitude
Stomach Neoplasms